Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 428

Sort by

Sort Order Select

Journal Articles

Intranasal Fentanyl and Impact of an Emergency Department Pain Protocol for Sickle Cell Disease on Hospitalization Rates

Olufuke Y Martin, Sean M Thompson, Matthew Hays, Seethal A Jacob

Blood Adv bloodadvances.2025016309.

https://doi.org/10.1182/bloodadvances.2025016309

Published: 2025

Includes: Supplemental data

Journal Articles

Immunoglobulin use, survival, and infection outcomes in patients with chronic lymphocytic leukemia

Sara Carrillo de Albornoz, Xin Zhang, Rainier Arnolda, Aleece MacPhail, Adam Irving, Alisa M. Higgins, Erica M. Wood, Zoe K. McQuilten, Dennis Petrie

Blood Adv (2025) 9 (20): 5367–5377.

https://doi.org/10.1182/bloodadvances.2025015867

Published: 2025

Includes: Supplemental data

Journal Articles

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers

Lewis T. Go, Lucas T. Go, Madugodaralalage D. S. K. Gunaratne, Alexandra P. Wolanskyj-Spinner, Aneel A. Ashrani, Michelle A. Elliott, Richard L. Godby, Christopher C. Hook, Leslie J. Padrnos, Rajiv K. Pruthi, Candido E. Rivera, Rachelle L. Rouse, Surbhi Shah, Marwan E. Shaikh, Mustaqeem A. Siddiqui, Meera Sridharan, Ewa M. Wysokinska, Ronald S. Go, Jithma P. Abeykoon

Blood Adv (2025) 9 (20): 5343–5346.

https://doi.org/10.1182/bloodadvances.2025016644

Published: 2025

Journal Articles

Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines

Ali Choaib, Aseel AlKhader, Muayad Azzam, Hassan Kawtharany, Marisol Betensky, Leslie Raffini, Rachel Bercovitz, Sara K. Vesely, Paul Monagle, Reem A. Mustafa

Blood Adv (2025) 9 (20): 5347–5349.

https://doi.org/10.1182/bloodadvances.2025017398

Published: 2025

Journal Articles

Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML

Abdulrahman Alhajahjeh, Kishan K. Patel, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Stuart Seropian, Lohith Gowda, Scott F. Huntington, Maximilian Stahl, Amer M. Zeidan, George Goshua, Jan Philipp Bewersdorf

Blood Adv (2025) 9 (20): 5234–5246.

https://doi.org/10.1182/bloodadvances.2025016532

Published: 2025

Includes: Supplemental data

Journal Articles

Comparative outcomes of HSCT with posttransplant cyclophosphamide in older adults: the impact of donor type

Yosra M. Aljawai, Jeremy Ramdial, Portia Smallbone, George Chen, Partow Kebriaei, Oren Pasvolsky, Uday Popat, Betul Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta

Blood Adv (2025) 9 (20): 5201–5206.

https://doi.org/10.1182/bloodadvances.2025016592

Published: 2025

Includes: Supplemental data

Journal Articles

Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures

Michelle H Lee, Yating Wang, Angel M. Cronin, Angela C Tramontano, Lachelle D. Weeks, Gabriela S Hobbs

Blood Adv bloodadvances.2025017168.

https://doi.org/10.1182/bloodadvances.2025017168

Published: 2025

Includes: Supplemental data

Journal Articles

Moving the needle on chronic GVHD of the lung

Julie R. Boiko, Kenneth R. Cooke

Blood Adv (2025) 9 (19): 5038–5039.

https://doi.org/10.1182/bloodadvances.2025017297

Published: 2025

Journal Articles

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Husham Sharifi, Carson Tyler Moss, Zayan Musa, Alexander Bell, Christian O’Donnell, Carlos Hernandez Borges, Efthymia Iliana Matthaiou, Laura Johnston, Craig J. Galban, Ajay Sheshadri, Gregory Yanik, Guang-Shing Cheng, Joe L. Hsu

Blood Adv (2025) 9 (19): 5024–5037.

https://doi.org/10.1182/bloodadvances.2025016122

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation

Alison Grazioli, Michael Plazak, Kate Willsey, Joseph Rabin, Raymond P. Rector, Leonid Belyayev, Allison S. Lankford, Thomas M. Scalea, Aakash Shah, Bradley S. Taylor, Mark T. Gladwin

Blood Adv (2025) 9 (19): 4881–4890.

https://doi.org/10.1182/bloodadvances.2025016368

Published: 2025

Includes: Supplemental data

Journal Articles

A standardized metric to define a successful transition from pediatric to adult care in sickle cell disease

Galia Pollock, Susanna Curtis

Blood Adv (2025) 9 (18): 4622–4623.

https://doi.org/10.1182/bloodadvances.2025017088

Published: 2025

Journal Articles

Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis

Andrea P. Chung, Jason T. Shafrin, Sachin Vadgama, Kristen Hurley, Miguel-Angel Perales, Leonard C. Alsfeld, Sanjana Muthukrishnan, Anik R. Patel, Gunjan L. Shah, Richard T. Maziarz

Blood Adv (2025) 9 (18): 4727–4735.

https://doi.org/10.1182/bloodadvances.2024015634

Published: 2025

Includes: Supplemental data

Journal Articles

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

Pierre Stephan, Roberta Di Blasi, Louise Roulin, Jean Galtier, Julien Calvani, Véronique Meignin, Marie Donzel, Alexandra Traverse-Glehen, Elsa Poullot, Marie Parrens, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Roch Houot, Francois-Xavier Gros, François Lemonnier, Emmanuel Bachy, Catherine Thieblemont, Pierre Sesques

Blood Adv (2025) 9 (18): 4693–4704.

https://doi.org/10.1182/bloodadvances.2025015834

Published: 2025

Includes: Supplemental data

Journal Articles

Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels

Rahul Banerjee, Meera Mohan, Kai Rejeski, Benjamin R. Puliafito, Diana D. Cirstea, Gurbakhash Kaur, Shonali Midha, Georgia J. McCaughan, Nikhil M. Kumar, Nikita Mehra, Bhausaheb Bagal, Noopur S. Raje

Blood Adv (2025) 9 (18): 4720–4726.

https://doi.org/10.1182/bloodadvances.2025016490

Published: 2025

Journal Articles

Estimation of benefit to bispecific antibodies in US patients with lymphoma and multiple myeloma

Fausto Alfredo Rios-Olais, Talal Hilal

Blood Adv (2025) 9 (18): 4673–4675.

https://doi.org/10.1182/bloodadvances.2025016176

Published: 2025

Includes: Supplemental data

Journal Articles

National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease

Stephanie Howe Guarino, Akshat Jain, Mohan Madisetti, Kenneth Rivlin, Payal C. Desai, Julie Kanter, Sophie Lanzkron, Deepa Manwani

Blood Adv (2025) 9 (18): 4585–4591.

https://doi.org/10.1182/bloodadvances.2025015909

Published: 2025

Includes: Supplemental data

Journal Articles

Biological Parenthood Rates Among Men with Sickle Cell Disease

Anyssa N Young, Sarah R Hayford, Sapuni S Chandrasena, Sara Conroy, Tanvi Karkare, Barbara L. Kroner, Allison A King, Robert M Cronin, Luca Badolato, Leena Nahata, Susan E Creary

Blood Adv bloodadvances.2025017458.

https://doi.org/10.1182/bloodadvances.2025017458

Published: 2025

Journal Articles

An AI Model Classifies Risks of Early Relapse Post-CAR T Cell Therapy in a Multi-Center Real-World Population with DLBCL

Michelle Wang, Krishna V Komanduri, Debajyoti Datta, Ayan Patel, Barbee Whitaker, Artur Belov, Benjamin Rubin, Rohit Vashist, Rosa Rodriguez-Monguio, Pelin Cinar, Steven A. Anderson, Atul J. Butte

Blood Adv bloodadvances.2025016375.

https://doi.org/10.1182/bloodadvances.2025016375

Published: 2025

Includes: Supplemental data

Journal Articles

Moving beyond the eyeball test for fitness assessment in AML

Samuel J. Yates, Heidi D. Klepin

Blood Adv (2025) 9 (17): 4488–4490.

https://doi.org/10.1182/bloodadvances.2025016235

Published: 2025

Journal Articles

A mixed methods study to understand the role of knowledge in transition among youth with sickle cell disease

Ashima Singh, Mahua Dasgupta, M. Muska Nataliansyah, Nicole Steiner, Jeffrey Karst, Meghan Miller, Joshua J. Field, Melissa Azul, Liliana E. Pezzin, Amanda M. Brandow

Blood Adv (2025) 9 (17): 4477–4485.

https://doi.org/10.1182/bloodadvances.2025015984

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Intranasal Fentanyl and Impact of an Emergency Department Pain Protocol for Sickle Cell Disease on Hospitalization Rates

Immunoglobulin use, survival, and infection outcomes in patients with chronic lymphocytic leukemia

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers

Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines

Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML

Comparative outcomes of HSCT with posttransplant cyclophosphamide in older adults: the impact of donor type

Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures

Moving the needle on chronic GVHD of the lung

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation

A standardized metric to define a successful transition from pediatric to adult care in sickle cell disease

Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels

Estimation of benefit to bispecific antibodies in US patients with lymphoma and multiple myeloma

National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease

Biological Parenthood Rates Among Men with Sickle Cell Disease

An AI Model Classifies Risks of Early Relapse Post-CAR T Cell Therapy in a Multi-Center Real-World Population with DLBCL

Moving beyond the eyeball test for fitness assessment in AML

A mixed methods study to understand the role of knowledge in transition among youth with sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only